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Abstract
Background: Imported malaria occurs as a relatively rare event in developed countries. As a
consequence, most clinicians have little experience in making clinical assessments of disease
severity and decisions regarding the need for parenteral therapy or high-level monitoring. In this
study, the diagnostic accuracy of procalcitonin (PCT) for severe Plasmodium falciparum disease was
assessed in a cohort of 100 consecutive travellers with various species of imported malaria.
Methods and results: In all patients, PCT was measured on admission with a semi-quantitative
'point-of-care' test. Patients with severe P. falciparum malaria had significantly higher median PCT
levels on admission as compared with patients with uncomplicated P. falciparum disease. In addition,
PCT levels in patients with non-falciparum malaria were also higher compared with patients with
non-severe falciparum malaria but lower compared with severe P. falciparum malaria. At a cut-off
point of 10 ng/mL, PCT had a sensitivity of 0,67 and a specificity of 0,94 for severe falciparum
disease. However, at lower cut-off points the specificity and positive predictive value were rather
poor although the sensitivity and negative predictive value remained high.
Discussion: Potential drawbacks in the interpretation of elevated PCT levels on admission may be
caused by infections with non-falciparum species and by concomitant bacterial infections.
Conclusion: Semi-quantitative determination of PCT on admission is of limited use in the initial
clinical assessment of disease severity in travellers with imported malaria, especially in settings with
limited experience with the treatment of malaria.
Background
Imported malaria occurs as a relatively rare event in devel-
oped countries. As a consequence, most clinicians have
little experience in making clinical assessments of disease
severity and decisions regarding the need for parenteral
therapy or high-level monitoring. In addition, obtaining a
correct diagnosis of malaria may be troublesome in cen-
tres where laboratory staff are less skilled in preparing
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cation of the causative Plasmodium species and quantifica-
tion of the parasite load [1]. These centres usually rely on
rapid diagnostic tests for the diagnosis of malaria. How-
ever, these tests do not provide any information about the
severity of the infection, which is mandatory for evalua-
tion of Plasmodium falciparum infections. Therefore, well-
validated, simple, laboratory-based prognostic markers
would be of great value in assisting clinicians dealing with
returned travellers with malaria. Unfortunately, many lab-
oratory markers including parasitaemia have poor sensi-
tivity, specificity and predictive values for estimating the
severity of disease [2].
Procalcitonin (PCT), a precursor peptide from the hor-
mone calcitonin, has been considered by some, but not
all, to be a specific and useful indicator of systemic bacte-
rial infections [3,4]. Interestingly, elevated PCT levels
(measured with quantitative assays), were also demon-
strated in several patient series with malaria [5-11]. In the
present study, the diagnostic accuracy of PCT for severe P.
falciparum disease was evaluated in a cohort of 100 con-
secutive travellers with various imported malaria species.
For this purpose, the PCT-Q® test was used, a semi-quanti-
tative immunochromatographic "point-of-care" test,
which, in contrast to quantitative PCT assays, allows a
rapid measurement of PCT without a need for further
technical equipment or support and can be easily incor-
porated in the initial clinical assessment of travellers who
return home ill.
Methods
Patient selection
The Harbour Hospital is a 161-bed general hospital
located in Rotterdam, the Netherlands. It also harbours
the Institute of Tropical Diseases, which serves as a
national referral centre for tropical diseases. All patients
reported herein were consecutive travellers diagnosed
with imported malaria, who were admitted to the Insti-
tute of Tropical Diseases of the Harbour Hospital in the
period January 2004 to December 2007 and participated
in the PCTTM (ProCalciTonin in Travel Medicine) obser-
vational survey. The PCTTM was an observational study
that had the aim of evaluating the diagnostic accuracy of
the semi-quantitative PCT-Q® test (see below) in the ini-
tial assessment of travellers who return home sick after a
stay in the tropics or sub-tropics. Of each traveller demo-
graphic, clinical and laboratory data were collected
including a blood sample on admission for PCT testing.
Patients were classified as having severe or complicated P.
falciparum malaria if they met pre-specified criteria for
severe malaria [2,12].
Laboratory methods
Routine examinations included red blood cell count, hae-
matocrit, white blood cell count, platelet count, serum
electrolytes, total bilirubin, serum creatinine, liver
enzymes, blood glucose and plasma lactate. Blood smears
(thin and thick films), were obtained from finger pricks
and stained with Giemsa and parasite counts were per-
formed. Malaria was diagnosed by QBC analysis, PfHRP-
2 screening and conventional microscopy with subse-
quent specification of the Plasmodium species (Plasmodium
falciparum, Plasmodium vivax, Plasmodium ovale or Plasmo-
dium malariae, respectively). In case of P. falciparum infec-
tions, parasite density was expressed as the number of P.
falciparum trophozoites per 100 red cells in a thin film or
the number of parasites per 100 white blood cells in a
thick film. The parasite load was calculated from these fig-
ures using the actual number of white or red blood cells
counted in the blood sample.
PCT was measured with the BRAHMS PCT-Q® test
(Brahms Diagnostics, Germany) according to the instruc-
tions of the manufacturer. PCT results were classified as
follows: a negative result or a PCT < 0,5 ng/ml was classi-
fied as "normal"; a PCT of 0,5 ng/ml or a PCT between 0,5-
2,0 ng/ml was classified as "low"; a PCT of 2,0 ng/ml or a
PCT between 2,0-10,0 was classified as "moderate"; a PCT
of 10,0 ng/ml and above 10 ng/ml was classified as "high"
as recommended [13].
Statistical methods
All values are presented as median (range). For compari-
son between groups, the Mann-Whitney U test, Kruskal-
Wallis test or Chi square test were used as appropriate.
Post-hoc analysis was performed using Mann-Whitney U
test. P values at α < 0.05 were considered statistically sig-
nificant.
Results
One hundred patients with imported malaria were
included in this study. Twenty-nine travellers acquired a
non-P. falciparum malaria infection (P. vivax n = 23; P.
ovale n = 4; P. malariae n = 2), 65 travellers had an uncom-
plicated P. falciparum infection, whereas another six
patients had severe P. falciparum disease. Thirty-one
patients with uncomplicated P. falciparum disease, one
patient with severe P. falciparum disease and eight patients
with non-P. falciparum disease were considered to be
semi-immune or partially immune, respectively. As
depicted in Table 1, patients with a severe P. falciparum
infection had the highest serum CRP, lactate, creatinine,
lactate dehydrogenase and bilirubin concentrations and
the lowest haemoglobin concentrations and platelet
counts on admission. As shown in Table 2, the median
PCT concentrations differed significantly between the
three groups (Chi-square 17.8; P < 0.001). The lowest
median PCT concentration was observed in the group of
patients with non-severe P. falciparum infections, whereas
patients with severe P. falciparum infections had the high-
est median PCT concentration (Table 2).Page 2 of 5
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were combined and analysed together, a significant corre-
lation between parasitaemia and PCT concentrations was
observed. Patients with a high PCT concentration had a
significantly higher parasitaemia compared with patients
who had a low or moderate PCT concentration (Figure 1).
Interestingly, in all patients with severe P. falciparum
malaria the elevated PCT levels on admission were classi-
fied as moderate (n = 2) or high (n = 4), respectively.
Depending on the selected cut-off point (Table 3), PCT
had an excellent sensitivity for severe P. falciparum disease,
whereas specificity was poor. At a cut-off point of 10 ng/
mL, the test characteristics became clinically relevant with
a sensitivity of 0,67 and a specificity of 0,94 for severe P.
falciparum disease.
Discussion
In this study, a semi-quantitative PCT test was evaluated
as a diagnostic tool for severe P. falciparum disease because
this 'point-of-care' test may be easily incorporated in the
initial clinical assessment of travellers who return home
ill, without a need for further technical equipment or sup-
port. To that end, PCT levels on admission were studied in
a broad spectrum of manifestations of imported malaria,
ranging from uncomplicated to severe P. falciparum
malaria, as well as in non-falciparum malaria. Interest-
ingly, in all patients with severe P. falciparum disease a
moderate to high level of PCT was seen on admission,
which agrees with observations made by others [6,8].
Some authors even suggested that an elevated PCT has
prognostic value based on observations that PCT levels >
25 ng/mL were related to a fatal outcome in six of seven
Table 1: General characteristics and laboratory findings on admission of 100 consecutive travellers with imported malaria, subdivided 
by causative Plasmodium species and disease severity.
Non-P. falciparum malaria Uncomplicated P. falciparum 
malaria
Severe P. falciparum malaria P value
(n = 29) (n = 65) (n = 6)
Male/female 22/7 47/18 4/2 0,8790
Age (year) 36 (15 - 62) 36 (9 - 67) 48 (29 - 55) 0,2077
Continent of acquisition
Africa 11 62 5
Asia 11 2 -
South America 6 - 1
Parasite load 
(trophozoites per uL)
- 3422 (23 - 385000) 174900 (80500 - 567000) 0,0002
Plasma lactate (mmol/L) 1,3 (0,7 - 2,2) * 1,5 (0,9 - 4,4) * 2,7 (1,8 - 5,8) 0,0083
ESR (mm/h) 19 (3 - 82) 16 (1 - 73) 17 (11 - 54) 0,1400
Haemoglobin (mmol/L) 8,0 (4,6 - 10,1) 8,7 (5,2 - 11,1) ° 7,4 (4,0 - 10,2) 0,0297
Leucocytes (× 109/L) 4,7 (1,9 - 9,3) 4,9 (1,8 - 9,0) 6,6 (3,2 - 18,5) 0,3867
Platelets (× 109/L) 95 (28 - 167) * 80 (11 - 247) * 22 (3 - 36) 0,0010
C-reactive protein (mg/L) 84 (18 -208) * 109 (5 - 280) # 175 (151 - 265) 0,0056
Plasma glucose (mmol/L) 6,6 (4,9 - 8,2) 6,8 (4,1 - 14,9) 5,9 (4,5 - 7,6) 0,3100
Serum creatinine (umol/L) 91 (62 - 223) * 95 (56 - 208) * 153 (112 - 199) 0,0028
Serum LDH (U/L) 474 (278 - 1133) * 554 (238 - 1234) * 1272 (787 - 2216) 0,0011
Serum total bilirubin (umol/L) 24 (10 - 84) * 26 (4 - 164) * 65 (39 - 269) 0,0033
* P < 0.01, compared with severe P. falciparum malaria
° P < 0.05, compared with non-P. falciparum malaria
# P < 0.05, compared with severe P. falciparum malaria
Table 2: Procalcitonin (PCT) levels on admission in relation to causative Plasmodium species.
PCT Non-P. falciparum malaria Uncomplicated P. falciparum malaria Severe P. falciparum malaria
Normal 4 23 0 27
Low 5 16 0 21
Moderate 14 22 2 38
High 6 4 4 14
29 65 6 100
Non-P. falciparum vs uncomplicated P. falciparum p = 0.004
Non-P. falciparum vs severe P. falciparum p = 0.031
Uncomplicated P. falciparum vs severe P. falciparum p < 0.001Page 3 of 5
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these assumptions were not validated in some other stud-
ies where PCT levels on admission were even higher (up
to 662 ng/mL) but without associated case-fatalities [8].
Interestingly, although severe or fatal malaria rarely
results from infections with the non-sequestering Plasmo-
dium species, P. vivax, P. ovale and P. malariae, increased
PCT levels were observed in the majority of these patients
on admission as well. Although speculative, these find-
ings may imply that the mechanism whereby PCT levels
increase in severe P. falciparum disease do not accurately
reflect pivotal pathophysiological events in complicated
P. falciparum disease, like sequestration of infected red
blood cells in the microcirculation of vital organs. Rather,
the elevation of PCT may be the result of activation of a
common host response to malaria parasites. In fact, some
even suggest that P. falciparum malaria per se is not associ-
ated with a stronger host response than P. vivax or P. ovale
malaria, but that the density of the infection of the causa-
tive Plasmodium species influences the extent of the host
response [14].
In the present study, PCT had an acceptable to excellent
sensitivity for severe P. falciparum disease and a high neg-
ative predictive value. Given the low percentage of false
negatives (i.e. patients with a low PCT on admission who
nonetheless experienced a complicated course of
malaria), the use of semi-quantitative PCT levels on
admission to guide to treatment, would result in only very
few patients with severe P. falciparum malaria being
denied high-level monitoring and intensive treatment.
However, the specificity and positive predictive value of
the semi-quantive PCT test were rather poor. Applying
semi-quantitative PCT levels on admission as a guide to
therapy would therefore lead to a large proportion of
patients receiving more intensive monitoring and treat-
ment than strictly necessary. In our opinion, only at a PCT
cut-off point of 10 ng/mL for severe P. falciparum disease,
the test characteristics were clinically valuable. Moreover,
in settings were the prevalence of malaria is lower than
that reported herein, the positive predictive value of PCT
will probably be even lower resulting in more false posi-
tive tests.
Procalcitonin (PCT) levels on admission in relation to para-site load in 71 patients with falciparum malariaFigure 1
Procalcitonin (PCT) levels on admission in relation 
to parasite load in 71 patients with falciparum 
malaria. Bars represent the median value of each group. 
Arrow heads indicate the patients with severe falciparum 
malaria. Statistical analysis showed an overall statistically sig-
nificant difference between the various PCT groups on 
admission (p = 0.0012). Post-hoc group-to-group analysis 
showed significant differences in parasite load (identified by 
the asterix sign *) between various PCT groups (Normal vs 
moderate, p = 0.0044; normal vs high, p = 0.0013; and low vs 
high, p = 0.0403, respectively).
Table 3: Descriptive statistics of the accuracy of procalcitonin (PCT) as a diagnostic tool for severe Plasmodium falciparum disease using 
various cut-off points.
PCT cut-off point
P. falciparum species only (n = 71) 0,5 ng/ml 2,0 ng/mL 10,0 ng/mL
Sensitivity 1,00 [n.a.] 1,00 [n.a.] 0,67 [0,56-0,78]
Specificity 0,35 [0,24-0,46] 0,60 [0,49-0,71] 0,94 [0,88-1,00]
Positive predictive value 0,13 [0,05-0,21] 0,19 [0,10-0,28] 0,50 [0,38-0,62]
Negative predictive value 1,00 [n.a.] 1,00 [n.a.] 0,97 [0,93-1,00]
All plasmodium species (n = 100) 0,5 ng/ml 2,0 ng/mL 10,0 ng/mL
Sensitivity 1,00 [n.a.] 1,00 [n.a.] 0,67 [0,58-0,76]
Specificity 0,29 [0,20-0,38] 0,51 [0,41-0,61] 0,94 [0,83-0,95]
Positive predictive value 0,08 [0,03-0,13] 0,19 [0,06-0,18] 0,50 [0,20-0,38]
Negative predictive value 1,00 [n.a.] 1,00 [n.a.] 0,97 [0,95-1,00]
Data is shown as proportion [95% confidence interval].Page 4 of 5
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Possibly, the overall sensitivity of PCT for the prediction
of the course of malaria, could be improved if PCT was
measured more precisely by use of an ultrasensitive PCT
assay instead of the semi-quantitative assay used in this
study. Several studies have directly compared the perform-
ance of both techniques and demonstrated satisfactory
but not complete, concordance [13,15]. However, in the
latter study [15], a satisfactory concordance was only
reached when results in the next category were included to
account for readout errors, which may further compro-
mise the applicability of this semi-quantitative test in clin-
ical practice.
Another drawback on the use of PCT for estimating
malaria severity might be the occurrence of bacterial co-
infection, which may also lead to elevated PCT levels on
admission. In a large French intensive care unit study on
imported severe falciparum malaria, 13 of 93 (14%)
patients with severe imported malaria were diagnosed
with a concomitant bacterial infection, which contributed
to a poor outcome [16]. However, in this study, blood cul-
tures were routinely taken on admission in case of fever
and remained negative, making the occurrence of con-
comitant bacteraemia a less likely event.
Conclusion
Severe P. falciparum disease and non-falciparum malaria
are associated with elevated PCT levels on admission.
Although determination of PCT may be of some help in
the initial clinical assessment of disease severity in travel-
lers with falciparum malaria in hospitals with extensive
experience with the treatment of malaria, the overall test
characteristics were too poor to advocate a general use of
this semi-quantitative PCT assay. Potential drawbacks in
the interpretation of elevated PCT levels on admission
may be caused by infections with non-falciparum Plasmo-
dium species and by concomitant bacterial infections.
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